The
Report Ocular Hypertension Global Clinical Trials Review, H2, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Ocular Hypertension Global Clinical Trials
Review, H2, 2016" provides an overview of Ocular Hypertension
clinical trials scenario. This report provides top line data relating
to the clinical trials on Ocular Hypertension. Report includes an
overview of trial numbers and their average enrollment in top
countries conducted across the globe. The report offers coverage of
disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
View Full Report at
http://www.marketresearchreports.biz/analysis/909355
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to
Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing to
Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to
Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries:
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries by
Trial Status 16
Clinical Trials by E7 Countries:
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries by
Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a Period
of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in
Ocular Hypertension Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Ocular Hypertension 30
Oct 27, 2016: Aerie
Pharmaceuticals Reports Positive Topline Efficacy Results of Rocket 4
Phase 3 Trial of Rhopressa (netarsudil ophthalmic solution) 0.02% 30
Oct 04, 2016: Ocular Therapeutix
Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP
(Sustained Release Travoprost) for the Treatment of Glaucoma and
Ocular Hypertension 31
Clinical Trial Profile Snapshots
32
Appendix 349
Abbreviations 349
Definitions 349
Research Methodology 350
Secondary Research 350
About GlobalData 351
Contact Us 351
Disclaimer 351
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment